TNFSF13B and myeloid sarcoma: Specifically, molecules promoting B cell recruitment and survival, such as CXCL13 and B cell activating factor (BAFF), are expressed by dendritic cells in the meninges[44,95] and by infiltrating lymphocytes and astrocytes within active MS[105,106] and EAE lesions[107].